EA200200294A1 - Сферические агломераты телитромицина, способ их получения и их применение для приготовления лекарственных форм - Google Patents

Сферические агломераты телитромицина, способ их получения и их применение для приготовления лекарственных форм

Info

Publication number
EA200200294A1
EA200200294A1 EA200200294A EA200200294A EA200200294A1 EA 200200294 A1 EA200200294 A1 EA 200200294A1 EA 200200294 A EA200200294 A EA 200200294A EA 200200294 A EA200200294 A EA 200200294A EA 200200294 A1 EA200200294 A1 EA 200200294A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
spherical
thyltromycine
aglomerates
production
Prior art date
Application number
EA200200294A
Other languages
English (en)
Other versions
EA005080B1 (ru
Inventor
Жан-Ив Годар
Валери Роньон-Раво
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200200294(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200200294A1 publication Critical patent/EA200200294A1/ru
Publication of EA005080B1 publication Critical patent/EA005080B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Предметом настоящего изобретения являются сферические агломераты телитромицина. Предметом изобретения является способ, отличающийся тем, что приготовляют суспензию кристаллов телитромицина и затем покрывают кристаллы фазой, не растворимой в телитромицине, которая постепенно закристаллизовывается. Сферические агломераты телитромицина находят свое применение в приготовлении микрокапсул.Отчет о международном поиске был опубликован 2001.06.21.
EA200200294A 1999-08-26 2000-08-28 Способ получения сферических агломератов телитромицина и их применение для приготовления лекарственных форм EA005080B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
EA200200294A1 true EA200200294A1 (ru) 2002-08-29
EA005080B1 EA005080B1 (ru) 2004-10-28

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200294A EA005080B1 (ru) 1999-08-26 2000-08-28 Способ получения сферических агломератов телитромицина и их применение для приготовления лекарственных форм

Country Status (34)

Country Link
US (1) US6825218B1 (ru)
EP (1) EP1212336B1 (ru)
JP (1) JP4871467B2 (ru)
KR (1) KR100718222B1 (ru)
CN (1) CN1183151C (ru)
AR (1) AR025398A1 (ru)
AT (1) ATE255590T1 (ru)
AU (1) AU774385B2 (ru)
BR (1) BR0013569B1 (ru)
CA (1) CA2382497C (ru)
CO (1) CO5190666A1 (ru)
CZ (1) CZ2002594A3 (ru)
DE (1) DE60006976T2 (ru)
DK (1) DK1212336T3 (ru)
EA (1) EA005080B1 (ru)
ES (1) ES2209970T3 (ru)
FR (1) FR2797875B1 (ru)
HK (1) HK1049167B (ru)
HR (1) HRP20020167B1 (ru)
HU (1) HU229075B1 (ru)
IL (2) IL148128A0 (ru)
ME (2) MEP20108A (ru)
MX (1) MXPA02001988A (ru)
NO (1) NO322622B1 (ru)
PL (1) PL204100B1 (ru)
PT (1) PT1212336E (ru)
RS (1) RS50433B (ru)
SI (1) SI1212336T1 (ru)
SK (1) SK287588B6 (ru)
TR (1) TR200200506T2 (ru)
TW (1) TWI272949B (ru)
UA (1) UA73523C2 (ru)
WO (1) WO2001014393A2 (ru)
ZA (1) ZA200201599B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ES2209970T3 (es) 2004-07-01
EP1212336B1 (fr) 2003-12-03
BR0013569A (pt) 2002-05-14
FR2797875B1 (fr) 2001-10-19
TWI272949B (en) 2007-02-11
PL353137A1 (en) 2003-10-20
TR200200506T2 (tr) 2002-08-21
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
HUP0202842A3 (en) 2003-03-28
UA73523C2 (ru) 2005-08-15
HU229075B1 (hu) 2013-07-29
JP4871467B2 (ja) 2012-02-08
WO2001014393A3 (fr) 2001-06-21
NO20020926D0 (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
MEP20108A (en) 2010-06-10
AR025398A1 (es) 2002-11-27
CA2382497A1 (fr) 2001-03-01
AU774385B2 (en) 2004-06-24
CN1183151C (zh) 2005-01-05
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
MXPA02001988A (es) 2002-08-20
US6825218B1 (en) 2004-11-30
EP1212336A2 (fr) 2002-06-12
FR2797875A1 (fr) 2001-03-02
RS50433B (sr) 2009-12-31
IL148128A (en) 2006-10-31
KR100718222B1 (ko) 2007-05-15
YU13202A (sh) 2004-09-03
CN1371386A (zh) 2002-09-25
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
PT1212336E (pt) 2004-04-30
HRP20020167B1 (en) 2006-06-30
KR20020033771A (ko) 2002-05-07
SK2532002A3 (en) 2002-09-10
HUP0202842A2 (hu) 2003-01-28
JP2003507484A (ja) 2003-02-25
HRP20020167A2 (en) 2003-06-30
DK1212336T3 (da) 2004-03-15
ME00112B (me) 2010-10-10
NO20020926L (no) 2002-02-26
IL148128A0 (en) 2002-09-12
WO2001014393A2 (fr) 2001-03-01
CO5190666A1 (es) 2002-08-29
DE60006976D1 (de) 2004-01-15
EA005080B1 (ru) 2004-10-28
SK287588B6 (sk) 2011-03-04
CA2382497C (fr) 2011-06-28
ATE255590T1 (de) 2003-12-15
DE60006976T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
FI970825A (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
DK0921789T3 (da) Væskesuspensioner med maskeret smag
EA200200294A1 (ru) Сферические агломераты телитромицина, способ их получения и их применение для приготовления лекарственных форм
NO874955L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
DK680788A (da) Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne
NO913008L (no) Fremgangsmaate for fremstilling av fenylacetamid-derivater.
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
FI963050A (fi) Menetelmä klavulaanihapposuolan valmistamiseksi
DE3481057D1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
ES2018757B3 (es) Procedimiento para la produccion de polvometalurgica de levas
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
AU6843498A (en) Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives
FI894119A0 (fi) Menetelmä isoseriini-N,N-dietikkahapon trinatriumsuolan valmistamiseksi
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO912636D0 (no) Fremgangsmaate for fremstilling av svovelsubstituerte mevininsyre-derivater.
NO924763L (no) Ny fremgangsmaate for fremstilling av 4-amino-5-hexensyre
MC2152A1 (fr) Procede de preparation du 10,10-dioxyde de 1-ethylphenoxathiine et ce compose ainsi prepare
NO903967D0 (no) Fremgangsmaate for fremstilling av dihydrocaffeinsyrederivater.
IS3947A (is) Amínósýru afleiður, aðferð til framleiðslu þeirraog notkunar sem lyfja
NO994793D0 (no) FremgangsmÕte for fremstilling av clavulansyre
FI945414A (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
NO995841D0 (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2-fenylpropionsyre-derivater
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU